Keymed Biosciences Inc. Share Price
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Hong Kong S.E.
07:46:16 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 73.65 HKD | +0.14% |
|
-7.46% | +38.07% |
| Market Cap | 18.55B 21.67B 2.76B 2.38B 2.24B 2.04B 3.82B 264B 3.85B 26.7B 10.28B 134B 10.38B 10.15B 426B | P/E 2026 * |
19.6x | P/E 2027 * | 1,295x |
|---|---|---|---|---|---|
| Enterprise Value | 17.17B 20.06B 2.56B 2.2B 2.08B 1.89B 3.53B 245B 3.57B 24.72B 9.51B 124B 9.61B 9.4B 394B | EV / Sales 2026 * |
10.2x | EV / Sales 2027 * | 8.21x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | +0.34% | ||
| 1 week | -7.46% | ||
| Current month | -1.67% | ||
| 1 month | -10.71% | ||
| 3 months | +32.85% | ||
| 6 months | +35.91% | ||
| Current year | +38.07% |
| 1 week | 71 |  | 80.8 |
| 1 month | 71 | | 84.3 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 22/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 02/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 28/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 22/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 02/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 20/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/06/25 | Moonshot Holdings Ltd.
| Other | Company | 21,600,000 | 7.7216% | |
| 11/06/25 | Moonshot Holdings Ltd.
| Other | Company | 18,800,000 | 6.7206% | |
| 15/09/23 | Moonshot Holdings Ltd.
| Other | Company | 114,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | -7.46% | -2.96% | +42.47% | 2.76B | |
| -0.25% | -1.36% | +44.08% | +102.76% | 68.24B | |
| -0.54% | -4.97% | +29.69% | +72.71% | 62.23B | |
| -1.18% | +0.47% | -12.78% | +384.69% | 27.8B | |
| -2.06% | -5.33% | +29.33% | +9.04% | 24.86B | |
| -1.76% | -6.30% | -4.55% | -19.75% | 24.22B | |
| -0.62% | -5.19% | +17.75% | -20.95% | 19.36B | |
| -1.86% | -2.22% | +202.03% | +353.89% | 17.28B | |
| -1.94% | -4.82% | -5.17% | +496.41% | 14.46B | |
| -1.54% | -2.88% | +52.33% | +159.75% | 14.23B | |
| Average | -1.14% | -3.84% | +34.98% | +158.10% | 27.54B | |
| Weighted average by Cap. | -1.01% | -3.16% | +34.91% | +135.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68B 1.96B 251M 216M 203M 185M 346M 23.96B 349M 2.42B 932M 12.15B 941M 920M 38.6B | 2.15B 2.51B 320M 275M 259M 236M 442M 30.57B 446M 3.09B 1.19B 15.51B 1.2B 1.17B 49.25B |
| Net income | 672M 786M 100M 86.17M 81.31M 74.07M 138M 9.58B 140M 968M 373M 4.86B 376M 368M 15.43B | -14.18M -16.56M -2.11M -1.82M -1.71M -1.56M -2.92M -202M -2.95M -20.41M -7.86M -102M -7.93M -7.76M -325M |
| Net Debt | -1.38B -1.61B -205M -177M -167M -152M -284M -19.64B -286M -1.99B -764M -9.96B -771M -755M -31.64B | -935M -1.09B -139M -120M -113M -103M -193M -13.32B -194M -1.35B -518M -6.76B -523M -512M -21.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | HK$73.65 | +0.14% | 2,067,360 |
| 10/09/26 | HK$73.55 | -3.73% | 2,102,604 |
| 09/09/26 | HK$76.40 | -3.90% | 1,976,946 |
| 08/09/26 | HK$79.50 | +1.79% | 895,820 |
| 07/09/26 | HK$78.10 | -2.07% | 863,707 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
